Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

Robert J. Motzer; Eric Jonasch; Shawna Boyle; Maria I. Carlo; Brandon Manley; Neeraj Agarwal; Ajjai Alva; Katy Beckermann; Toni K. Choueiri; Brian A. Costello; Ithaar H. Derweesh; Arpita Desai; Saby George; John L. Gore; Naomi Haas; Steven L. Hancock; Christos Kyriakopoulos; Elaine T. Lam; Clayton Lau; Bryan Lewis; David C. Madoff; Brittany McCreery; M. Dror Michaelson; Amir Mortazavi; Lakshminarayanan Nandagopal; Phillip M. Pierorazio; Elizabeth R. Plimack; Lee Ponsky; Sundhar Ramalingam; Brian Shuch; Zachary L. Smith; Bradley Somer; Jeffrey Sosman; Mary A. Dwyer; Angela D. Motter

doi:10.6004/jnccn.2020.0043

Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

Robert J. Motzer, Eric Jonasch, Shawna Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Christos Kyriakopoulos, Elaine T. Lam, Clayton Lau, Bryan LewisDavid C. Madoff, Brittany McCreery, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Phillip M. Pierorazio, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Bradley Somer, Jeffrey Sosman, Mary A. Dwyer, Angela D. Motter

Research output: Contribution to journal › Article › peer-review

173 Scopus citations

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.

Original language	English
Pages (from-to)	1160-1170
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	18
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2020.0043
State	Published - Sep 2020

Access to Document

10.6004/jnccn.2020.0043

Cite this

Motzer, R. J., Jonasch, E., Boyle, S., Carlo, M. I., Manley, B., Agarwal, N., Alva, A., Beckermann, K., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Desai, A., George, S., Gore, J. L., Haas, N., Hancock, S. L., Kyriakopoulos, C., Lam, E. T., Lau, C., ... Motter, A. D. (2020). Kidney cancer, version 1.2021: Featured updates to the nccn guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 18(9), 1160-1170. https://doi.org/10.6004/jnccn.2020.0043

@article{331b99c9bf0540719adb69b76fcf5dce,

title = "Kidney cancer, version 1.2021: Featured updates to the nccn guidelines",

abstract = "The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.",

author = "Motzer, {Robert J.} and Eric Jonasch and Shawna Boyle and Carlo, {Maria I.} and Brandon Manley and Neeraj Agarwal and Ajjai Alva and Katy Beckermann and Choueiri, {Toni K.} and Costello, {Brian A.} and Derweesh, {Ithaar H.} and Arpita Desai and Saby George and Gore, {John L.} and Naomi Haas and Hancock, {Steven L.} and Christos Kyriakopoulos and Lam, {Elaine T.} and Clayton Lau and Bryan Lewis and Madoff, {David C.} and Brittany McCreery and Michaelson, {M. Dror} and Amir Mortazavi and Lakshminarayanan Nandagopal and Pierorazio, {Phillip M.} and Plimack, {Elizabeth R.} and Lee Ponsky and Sundhar Ramalingam and Brian Shuch and Smith, {Zachary L.} and Bradley Somer and Jeffrey Sosman and Dwyer, {Mary A.} and Motter, {Angela D.}",

year = "2020",

month = sep,

doi = "10.6004/jnccn.2020.0043",

language = "English",

volume = "18",

pages = "1160--1170",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "9",

}

Motzer, RJ, Jonasch, E, Boyle, S, Carlo, MI, Manley, B, Agarwal, N, Alva, A, Beckermann, K, Choueiri, TK, Costello, BA, Derweesh, IH, Desai, A, George, S, Gore, JL, Haas, N, Hancock, SL, Kyriakopoulos, C, Lam, ET, Lau, C, Lewis, B, Madoff, DC, McCreery, B, Michaelson, MD, Mortazavi, A, Nandagopal, L, Pierorazio, PM, Plimack, ER, Ponsky, L, Ramalingam, S, Shuch, B, Smith, ZL, Somer, B, Sosman, J, Dwyer, MA & Motter, AD 2020, 'Kidney cancer, version 1.2021: Featured updates to the nccn guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 18, no. 9, pp. 1160-1170. https://doi.org/10.6004/jnccn.2020.0043

TY - JOUR

T1 - Kidney cancer, version 1.2021

T2 - Featured updates to the nccn guidelines

AU - Motzer, Robert J.

AU - Jonasch, Eric

AU - Boyle, Shawna

AU - Carlo, Maria I.

AU - Manley, Brandon

AU - Agarwal, Neeraj

AU - Alva, Ajjai

AU - Beckermann, Katy

AU - Choueiri, Toni K.

AU - Costello, Brian A.

AU - Derweesh, Ithaar H.

AU - Desai, Arpita

AU - George, Saby

AU - Gore, John L.

AU - Haas, Naomi

AU - Hancock, Steven L.

AU - Kyriakopoulos, Christos

AU - Lam, Elaine T.

AU - Lau, Clayton

AU - Lewis, Bryan

AU - Madoff, David C.

AU - McCreery, Brittany

AU - Michaelson, M. Dror

AU - Mortazavi, Amir

AU - Nandagopal, Lakshminarayanan

AU - Pierorazio, Phillip M.

AU - Plimack, Elizabeth R.

AU - Ponsky, Lee

AU - Ramalingam, Sundhar

AU - Shuch, Brian

AU - Smith, Zachary L.

AU - Somer, Bradley

AU - Sosman, Jeffrey

AU - Dwyer, Mary A.

AU - Motter, Angela D.

PY - 2020/9

Y1 - 2020/9

N2 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.

AB - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.

UR - http://www.scopus.com/inward/record.url?scp=85090506174&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2020.0043

DO - 10.6004/jnccn.2020.0043

M3 - Article

C2 - 32886895

AN - SCOPUS:85090506174

SN - 1540-1405

VL - 18

SP - 1160

EP - 1170

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this